Chlorpheniramine maleate and Liver function test abnormal - a phase IV clinical study of FDA data

Summary:

Liver function test abnormal is reported as a side effect among people who take Chlorpheniramine maleate (chlorpheniramine maleate), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Omeprazole, and have Pain.

The phase IV clinical study analyzes which people have Liver function test abnormal when taking Chlorpheniramine maleate. It is created by eHealthMe based on reports of 7,278 people who have side effects when taking Chlorpheniramine maleate from the FDA, and is updated regularly.

What is Chlorpheniramine maleate?

Chlorpheniramine maleate has active ingredients of chlorpheniramine maleate. It is often used in allergies. eHealthMe is studying from 7,632 Chlorpheniramine maleate users. Check the latest studies of Chlorpheniramine maleate.

What is Liver function test abnormal?

Liver function test abnormal is found to be associated with 1,494 drugs and 1,963 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

7,278 people reported to have side effects when taking Chlorpheniramine maleate.
Among them, 54 people (0.74%) have Liver function test abnormal.

Could Chlorpheniramine maleate cause Liver function test abnormal?

Among these 54 people:

How long have people been on Chlorpheniramine maleate when they have Liver function test abnormal? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Liver function test abnormal when taking Chlorpheniramine maleate? *

  • female: 54.17 %
  • male: 45.83 %

What is the age of people who have Liver function test abnormal when taking Chlorpheniramine maleate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 50.0 %
  • 20-29: 4.35 %
  • 30-39: 2.17 %
  • 40-49: 0.0 %
  • 50-59: 21.74 %
  • 60+: 21.74 %

What are other drugs people take besides Chlorpheniramine maleate? *

  1. Omeprazole: 39 people, 72.22%
  2. Ondansetron: 32 people, 59.26%
  3. Allopurinol: 31 people, 57.41%
  4. Acetaminophen: 30 people, 55.56%
  5. Voriconazole: 28 people, 51.85%
  6. Cyclosporine: 28 people, 51.85%
  7. Ketalar: 25 people, 46.30%
  8. Morphine: 23 people, 42.59%
  9. Acyclovir: 23 people, 42.59%
  10. Etopophos Preservative Free: 14 people, 25.93%

What are other side effects people have besides Liver function test abnormal? *

  1. Hepatotoxicity (chemical-driven liver damage): 30 people, 55.56%
  2. Dilatation Intrahepatic Duct Acquired: 29 people, 53.70%
  3. Venoocclusive Liver Disease (small veins in the liver are obstructed): 17 people, 31.48%
  4. Venoocclusive Disease (small veins in the liver are obstructed): 14 people, 25.93%
  5. Alanine Aminotransferase Increased: 8 people, 14.81%
  6. Autoimmune Hepatitis: 7 people, 12.96%
  7. Constipation: 7 people, 12.96%
  8. Blood Alkaline Phosphatase Increased: 6 people, 11.11%
  9. Blood Bilirubin Increased: 6 people, 11.11%
  10. Thrombocytopenia (decrease of platelets in blood): 6 people, 11.11%

What are the existing conditions these people have? *

  1. Pain: 29 people, 53.70%
  2. Lung Cancer - Non-Small Cell (lung cancer): 6 people, 11.11%
  3. Neoplasm Malignant (cancer tumour): 5 people, 9.26%
  4. Aplastic Anemia: 3 people, 5.56%
  5. Glioma (a type of tumour that starts in the brain or spine): 3 people, 5.56%
  6. Aortic Thrombosis (formation of a blood clot inside aorta): 2 people, 3.70%
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 3.70%
  8. Hiv Infection: 2 people, 3.70%
  9. Tumor: 2 people, 3.70%
  10. Essential Hypertension (primary hypertension): 1 person, 1.85%

* Approximation only. Some reports may have incomplete information.

Do you take Chlorpheniramine maleate and have Liver function test abnormal?

- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Chlorpheniramine maleate:

Liver function test abnormal treatments and more:

How severe was Liver function test abnormal and when was it recovered:

Expand to all the drugs that have ingredients of chlorpheniramine maleate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Chlorpheniramine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function test abnormal:

Browse all the conditions that are associated with Liver function test abnormal:


How the study uses the data?

The study uses data from the FDA. It is based on chlorpheniramine maleate (the active ingredients of Chlorpheniramine maleate) and Chlorpheniramine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: